Raymond James & Associates Acquires 1,375 Shares of BlackRock Health Sciences Trust (NYSE:BME)

Raymond James & Associates lifted its holdings in shares of BlackRock Health Sciences Trust (NYSE:BME) by 3.5% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 40,673 shares of the company’s stock after purchasing an additional 1,375 shares during the period. Raymond James & Associates’ holdings in BlackRock Health Sciences Trust were worth $1,646,000 at the end of the most recent reporting period.

Other large investors also recently made changes to their positions in the company. AdvisorNet Financial Inc bought a new stake in shares of BlackRock Health Sciences Trust during the third quarter worth $31,000. Stonebridge Capital Advisors LLC acquired a new position in shares of BlackRock Health Sciences Trust during the third quarter valued at $31,000. Pathstone Family Office LLC bought a new position in BlackRock Health Sciences Trust in the fourth quarter valued at about $252,000. JPMorgan Chase & Co. bought a new position in BlackRock Health Sciences Trust in the first quarter valued at about $115,000. Finally, PNC Financial Services Group Inc. boosted its holdings in BlackRock Health Sciences Trust by 360.4% in the first quarter. PNC Financial Services Group Inc. now owns 3,628 shares of the company’s stock valued at $166,000 after acquiring an additional 2,840 shares during the last quarter.

BlackRock Health Sciences Trust Trading Down 0.3 %

BlackRock Health Sciences Trust stock opened at $38.74 on Friday. The business’s 50-day simple moving average is $41.25 and its 200 day simple moving average is $39.99. BlackRock Health Sciences Trust has a 12-month low of $35.53 and a 12-month high of $43.20.

BlackRock Health Sciences Trust Dividend Announcement

The company also recently declared a monthly dividend, which will be paid on Tuesday, April 30th. Investors of record on Monday, April 15th will be issued a $0.213 dividend. This represents a $2.56 annualized dividend and a yield of 6.60%. The ex-dividend date is Friday, April 12th.

BlackRock Health Sciences Trust Company Profile

BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services.